2020 annual financial data

enGene Therapeutics 2020 Operating margin

enGene Therapeutics 2020 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -13,853,000 USD and net income was -15,068,000 USD.
Operating cash flow was -13,061,000 USD.

Get free enGene Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-13,853,000 USD
Net income
-15,068,000 USD
Operating cash flow
-13,061,000 USD